Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roslin Russell

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Breast Cancer Research : BCR|June 14, 2015
MicroRNA profiling of the pubertal mouse mammary gland identifies miR-184 as a candidate breast tumour suppressor geneYu Wei Phua, Akira Nguyen, Daniel L Roden, et al.
Nucleic Acids Research|July 21, 2006
An open-access long oligonucleotide microarray resource for analysis of the human and mouse transcriptomesKévin Le Brigand, Roslin Russell, Chimène Moreilhon, et al.
Cell Reports|September 29, 2015
APOBEC3B-Mediated Cytidine Deamination Is Required for Estrogen Receptor Action in Breast CancerManikandan Periyasamy, Hetal Patel, Chun-Fui Lai, et al.
Molecular Oncology|June 2, 2014
Genomic and protein expression analysis reveals flap endonuclease 1 (FEN1) as a key biomarker in breast and ovarian cancerTarek M A Abdel-Fatah, Roslin Russell, Nada Albarakati, et al.
Oncotarget|November 12, 2015
Expression of androgen receptor splice variants in clinical breast cancersTheresa E Hickey, Connie M Irvine, Heidi Dvinge, et al.
EMBO Molecular Medicine|February 14, 2015
Navigator-3, a modulator of cell migration, may act as a suppressor of breast cancer progressionHadas Cohen-Dvashi, Nir Ben-Chetrit, Roslin Russell, et al.
European Urology|November 18, 2015
The Early Effects of Rapid Androgen Deprivation on Human Prostate CancerGreg L Shaw, Hayley Whitaker, Marie Corcoran, et al.
EMBO Molecular Medicine|April 17, 2014
HES6 drives a critical AR transcriptional programme to induce castration-resistant prostate cancer through activation of an E2F1-mediated cell cycle networkAntonio Ramos-Montoya, Alastair D Lamb, Roslin Russell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 7, 2022
A Phase 1 First-in-Human Study of FS118, a Tetravalent Bispecific Antibody Targeting LAG-3 and PD-L1 in Patients with Advanced Cancer and PD-L1 ResistanceTimothy A Yap, Patricia M LoRusso, Deborah J Wong, et al.
Science Signaling|January 22, 2015
Synaptojanin 2 is a druggable mediator of metastasis and the gene is overexpressed and amplified in breast cancerNir Ben-Chetrit, David Chetrit, Roslin Russell, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Breast Cancer Research : BCR|June 14, 2015
MicroRNA profiling of the pubertal mouse mammary gland identifies miR-184 as a candidate breast tumour suppressor geneYu Wei Phua, Akira Nguyen, Daniel L Roden, et al.
Nucleic Acids Research|July 21, 2006
An open-access long oligonucleotide microarray resource for analysis of the human and mouse transcriptomesKévin Le Brigand, Roslin Russell, Chimène Moreilhon, et al.
Cell Reports|September 29, 2015
APOBEC3B-Mediated Cytidine Deamination Is Required for Estrogen Receptor Action in Breast CancerManikandan Periyasamy, Hetal Patel, Chun-Fui Lai, et al.
Molecular Oncology|June 2, 2014
Genomic and protein expression analysis reveals flap endonuclease 1 (FEN1) as a key biomarker in breast and ovarian cancerTarek M A Abdel-Fatah, Roslin Russell, Nada Albarakati, et al.
Oncotarget|November 12, 2015
Expression of androgen receptor splice variants in clinical breast cancersTheresa E Hickey, Connie M Irvine, Heidi Dvinge, et al.
EMBO Molecular Medicine|February 14, 2015
Navigator-3, a modulator of cell migration, may act as a suppressor of breast cancer progressionHadas Cohen-Dvashi, Nir Ben-Chetrit, Roslin Russell, et al.
European Urology|November 18, 2015
The Early Effects of Rapid Androgen Deprivation on Human Prostate CancerGreg L Shaw, Hayley Whitaker, Marie Corcoran, et al.
EMBO Molecular Medicine|April 17, 2014
HES6 drives a critical AR transcriptional programme to induce castration-resistant prostate cancer through activation of an E2F1-mediated cell cycle networkAntonio Ramos-Montoya, Alastair D Lamb, Roslin Russell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 7, 2022
A Phase 1 First-in-Human Study of FS118, a Tetravalent Bispecific Antibody Targeting LAG-3 and PD-L1 in Patients with Advanced Cancer and PD-L1 ResistanceTimothy A Yap, Patricia M LoRusso, Deborah J Wong, et al.
Science Signaling|January 22, 2015
Synaptojanin 2 is a druggable mediator of metastasis and the gene is overexpressed and amplified in breast cancerNir Ben-Chetrit, David Chetrit, Roslin Russell, et al.
Pageof 4